Klinisk bakgrund som fysioterapeut med specialistexamen inom hjärta/kärl. Med doktor och arbetar som lektor på Högskolan Väst och som forskningsfysioterapeut i NU-sjukvården i Trollhättan. 

Disputerade 2020 med en avhandling som handlar om fysisk kapacitet för sköra äldre patienter inom sjukhusvården. Är numera involverad i forskningsprojekt som rör skörhet och skörhetsskattning, men även projekt inom hjärta/kärlområdet och träning.

Deltar i följande:
Tisdag 23/8 10:15-11:45 - Vårdvetenskap/SIKT Sent i livet, mitt i vården. Den äldre patienten inom kirurgi och trauma.

Docent, överläkare, dubbelspecialist i onkologi och klinisk genetik på Karolinska Universitetssjukhuset i Solna.

 

Forskargruppsledare för ett team på Karolinska Institutet, institutionen för Onkologi-Patologi där forskningen syftar till ett förbättrat patientomhändertagande inom klinisk onkologi med specifikt fokus på ärftlig cancer och bröstcancer. Projekten innefattar bland annat användningen av cirkulerande tumör-DNA som en biomarkör för prediktion och karakterisering av mutationer i den svenska TP53-kohorten. Svetlana är också drivande vad gäller doktorandutbildning för kliniker och är ordförande för den nationella forskarskolan i translationell onkologi (NatiOn).

 

Hon är också processledare för Ärftlig cancer inom RCC Stockholm-Gotland och kvalitetsregisterhållare för det Nationella Onkogenetiska kvalitetsregistret (NOGA) samt svensk koordinator för i det europeiska referensnätverket för genetiska tumörrisksyndrom (ERN GENTURIS).

Deltar i följande:
Fredag 26/8 12:00-13:30 - SFFB Det andra bröstet

Professor J. Calvin Coffey is the Foundation Chair, Professor of Surgery and Head of Surgery at the University of Limerick Hospital Group (ULHG)

and University of Limerick, in Ireland.

 

He was born in Cork City, Ireland. He obtained a BSc in Anatomy in 1995 and an MB in 1998, both from University College Cork (UCC), Ireland. He was awarded a PhD from UCC in 2005. He obtained a Fellowship of the Royal College of Surgeons in Ireland in 2009. He is an alumnus of the Digestive Diseases and Surgery Institute in the Cleveland Clinic (Ohio), having completed a fellowship in Colorectal Surgery in 2010. After completing surgical training in 2010, he was awarded Chair of Surgery at ULHG. He is currently Head of the Department of Surgery at ULHG.

 

Since taking up the post he and his team developed the robotic surgical program at ULHG. His operative workload consists of mostly cancer and inflammatory bowel disease related surgery. His main research focus is on anatomy directly relevant to surgical practice. This research has led to fundamental advances in human anatomy. Their findings have already been integrated in foundation texts (i.e., Gray’s Anatomy) and have led to the development of several new techniques in colorectal surgery, and radiology.

 

He has received numerous international awards including the James IV Travelling Fellowship and a Distinguished Alumnus Lectureship from the Cleveland Clinic. He has recently received an Alumnus Achievement Award by UCC, in recognition of research on the mesentery. This is the highest accolade the university bestows on its alumni. He has delivered several

international named lectures and invited lectures. He has authored two surgical texts, published several hundred original articles, and contributed chapters to reference texts

Deltar i följande:
Tisdag 23/8 15:15-16:15 - IHRE-föreläsning, The mesentery - our new organ

Mark G Coleman

MBChB, FRCS(Gen Surg), MD, honFRCPSG, FFSTRCSEd, honFCLS (India)

 

Consultant Surgeon, Plymouth Hospitals NHS Trust UK

 

• Chairman of the Joint Advisory Group for GI Endoscopy (JAG) (thejag.org.uk)


• Co-director Lapco International Consultancy (lapco-international.com)


• Lead Clinician, National Training Programme in Laparoscopic Colorectal Surgery 2008-2013


• Chairman of External Affairs, The Association of Coloproctology of Great Britain and Ireland 2011-2016 (acpgbi.org.uk)


• Chairman, Bowel Cancer West (Charity) (bowelcancerwest.com)


• Honorary Senior Lecturer (Associate Professor) Plymouth University Peninsula School of Medicine and Dentistry


• Fellow of the Faculty of Surgical Trainers, The Royal College of Surgeons of Edinburgh


• Clinical Director, Department of Colorectal Surgery, University Hospitals Plymouth


• Honorary membership, Australian Gynaecological Endoscopists Society and the Bulgarin Surgical Society


• Honorary Fellow, Royal College of Physicians and Surgeons of Glasgow and the College of Laparoscopic Surgeons of India

Deltar i följande:
Måndag 22/8 13:25-13:45 - AI in surgical education

Dr. Jamie Coleman is an Associate Professor of Surgery and the Vice-Chair of Wellness in the Department of Surgery at the University of Louisville. She is an acute care surgeon specializing in trauma, emergency general surgery and surgical critical care. She completed her general surgery residency in Chicago at Cook County Hospital and Rush University and her trauma and surgical critical care fellowship in Atlanta at Grady Memorial Hospital with Emory University.

Deltar i följande:
Tisdag 23/8 13:00-14:30 - SOTA 2 Trauma: Transfusion in Trauma

Deltar i följande:
Torsdag 25/8 13:00-14:30 - SFFB/Plastik Direktrekonstruktion vid mastektomi med efterföljande strålbehandling. Evidens som talar för och emot, eller finns där evidens för en medelväg?
Tisdag 23/8 13:05-13:17 - Patientrapporterade armbesvär och hälsorelaterad livskvalitet ett år efter sentinel node biopsi med eller utan axillutrymning från den randomiserade SENOMAC studien
Torsdag 25/8 15:15-15:23 - Capsular inflammation after immediate breast reconstruction – gene expression patterns and inflammatory cell infiltration in irradiated and non-irradiated breasts
Torsdag 25/8 09:10-09:18 - AXSANA: an international prospective cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemot
Torsdag 25/8 09:18-09:30 - Long-term outcomes of immediate implant-based breast reconstruction with and without radiotherapy in a large population-based cohort of breast cancer patients
Fredag 26/8 09:10-09:20 - Överlevnad och axillrecidiv hos bröstcancerpatienter med makrometastas i sentinel node som inte genomgår kompletterande axillutrymning – en internationell randomiserad studie (SENOMAC)
Torsdag 25/8 09:02-09:10 - Long-term outcomes of immediate implant-based breast reconstruction in older adults - a large population-based cohort of breast cancer patients
Fredag 26/8 09:20-09:30 - The role of major surgical postoperative complications for survival outcomes in breast cancer: a Swedish population-based register study in 57152 women

Clinical lead for the innovative and award winning POPS (Perioperative medicine for Older People undergoing Surgery) service.

Honorary Reader at King’s College London and Associate Professor at University College London, with research interests including preoperative assessment and optimisation, health services research focusing on perioperative pathways and postoperative delirium.

Education and training role, having established the first foundation and specialist registrar training programmes in perioperative medicine, co-authored e-learning modules, MSc modules and multiple textbook chapters.

National roles include Deputy Director for Centre for Perioperative Care, immediate past Vice President Clinical Quality British Geriatrics Society and involvement in a variety of steering, advisory and guideline groups (NELA, RCoA, BGS and NICE).

Deltar i följande:
Måndag 22/8 09:30-11:00 - SOTA1 Stockholm. When not to operate.
Måndag 22/8 10:10-10:50 - Erfarenheter från NHS

Deltar i följande:
Torsdag 25/8 13:00-14:30 - SFFB/Plastik Direktrekonstruktion vid mastektomi med efterföljande strålbehandling. Evidens som talar för och emot, eller finns där evidens för en medelväg?

Sahlgrenska Universitetssjukhuset Göteborg

Deltar i följande:
Måndag 22/8 13:00-14:30 - Kolorektal Appendixneoplasier

Dr. Marcos Gomez is a Senior Consultant Colorectal Surgeon, Colorectal Surgery Unit, Hospital Universitario Marques de Valdecilla, Santander, Reino de España and member of ESCP Education Committee, Steering Committee Member for Colorectal Surgery Working Group.

Between 2010 and 2011 he was trained as an instructor in medical simulation at the Center for Medical Simulation in Boston MIT-Harvard University. Since 2011 he has been the director and instructor of numerous courses in minimally invasive colorectal surgery in Hospital virtual Valdecilla. EBSQ-Coloproctology certified in 2017. He is a Steering Committee Member of the ESCP Colorectal Robotic Surgery Working Group.

His clinical activity is mainly focused in the treatment of colorectal cancer, inflammatory bowel disease and diverticular through minimally invasive surgery.

He is the principal investigator of a Pan European trial, prospective, multi-center, 4 parallel cohorts to compare peri-operative complications after RAS and laparoscopic right colectomy with intracorporeal vs extracorporeal anastomosis techniques. This trial, called MIRCAST (Minimally Invasive Right Colectomy Anastomosis Study), is endorsed by the ESCP and will recruit 1200 patients.

The team in Valdecilla started the Robotic Colorectal Surgery program in late 2010, is an ERAS reference center and he has performed more than 700 personal, and more than 1000 as a team, currently on two da Vinci Xi and X for benign complex and malignant procedures including LAR, Right Hemicolectomy CME with ICA with positive long term clinical and oncological outcomes.

 

Deltar i följande:
Tisdag 23/8 09:30-10:15 - Intuitive Workshop M5. Da Vinci assisted CME with ICA, the optimal combination
Tisdag 23/8 12:00-12:30 - Intuitive lunch symposium. Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST)

Deltar i följande:
Torsdag 25/8 13:00-14:30 - SFFB/Plastik Direktrekonstruktion vid mastektomi med efterföljande strålbehandling. Evidens som talar för och emot, eller finns där evidens för en medelväg?
Fredag 26/8 08:30-09:30 - Plastik Fria föredrag
Torsdag 25/8 16:05-16:13 - Är patienter mer nöjda med direktbröstrekonstruktion med syntetiskt eller biologiskt nät - 5 år efter operationen?
Torsdag 25/8 15:25-15:33 - Jämförelse av patientrapporterat utfall efter senrekonstruktion med DIEP respektive latissimus hos strålade patienter - vilka bröstspecifika aspekter är viktiga på lång sikt?

Deltar i följande:
Torsdag 25/8 14:30-15:15 - Motiva Workshop M4: Clinical experience with implants and tissue expanders in reconstructive breast surgery after mastectomy

Läkarchef, akutkliniken

Deltar i följande:
Torsdag 25/8 10:15-11:45 - Akutläkare - kirurgins räddning?

Ylva Hellstadius

leg. sjuksköterska/med. dr steg 1 utbildad i psykoterapi. Ordförande i nationella vårdprogrammet i cancerrehabilitering. Forskar om utvecklingen av psykologiska konsekvenser efter cancerbehandling. Speciellt intresserad av utvecklingen av symptom på posttraumatisk stress i cancerpopulationen.

Deltar i följande:
Onsdag 24/8 13:15-14:45 - Vårdvetenskap Patientrapporterade utfallsmått i forskning och Psykologiska konsekvenser vid stor kirurgi
Onsdag 24/8 14:00-14:45 - Psykologiska konsekvenser vid stor kirurgi

A long-time investigator with the NSABP, Dr Hyams was the group’s Executive Medical Officer and Director of Medical Affairs.

He is currently Director of Desert Surgical Oncology at Eisenhower Medical Center in Southern California, with a clinical focus on breast cancer, melanoma, and soft tissue malignancies. Oncoplastic reconstructive procedures are an important part of his surgical practice.

Dr. Hyams is an author, lecturer, and investigator. He serves as advisor and consultant for several molecular diagnostics companies, working in the US and internationally, to advance individualised biologically-directed care.

Deltar i följande:
Torsdag 25/8 12:30-13:00 - Exact Sciences lunchsymposium: What surgeons need to know about gene expression analyses in early breast cancer – the impact of the Oncotype DX® test in clinical practice

Catharina ” Cia” Ihre Lundgren; överläkare på ME Bröst, Endokrina tumörer och sarkom på Karolinska Universitetssjukhuset i Solna. Arbetar som specialist inom både bröst och endokrin sedan mer än 20 år tillbaka. Docent vid KI, med flera pågående forskningsprojekt inom framförallt tyroideacancer. 

Ordförande i Svensk Kirurgisk Förening & vice ordförande i Svenska Läkaresällskapet. 

Deltar i följande:
Torsdag 25/8 15:15-16:15 - KIRUB Halskirurgi - CIAs hemligheter
Måndag 22/8 10:06-10:24 - Jodaviditet i primärtumör förutsäger jodupptag i metastaser av papillär och lågt differentierad tyreoideacancer

Clinical work in anaesthesia & Intensive care since 1979 - Consultant Anaesthetist Danderyd
University Hospital 2011 —
Medical Director/Head of Research, Education, Development and Patient Safety Depart Anaesthesia & Intensive Care, Danderyds Hospital 2016 - 2019

Adjunct Professor of Anaesthesia & Intensive Care; Institution for Clinical Science, Karolinska
Institutet Danderyds University Hospital October 2012 -

Tutor: Main tutor for 4 PhD Thesis, Co-tutor for 4 PhD thesis, ongoing 3 PhD's Medical student
tutor T8 project support; 62
ST-project leads, 12
Scientific production: +140 peer reviewed Publications

Text Book - Anaesthesia for Day Case Surgery. Jan Jakobsson, Oxford Anaesthesia Library, Oxford
University Press 2009, ISBN 978-0-19-957713-2
Author of seven Chapters in Anaesthesia Text books
>l50 international lectures
> 100 review tasks for anaesthesia journals

Chairman of the Swedish Association of Day Surgery 2011-2017

Section Editor Regional Anaesthesia F1000 —
+l50 Referee tasks for international anaesthesia/intensive care journals Member of the Ethical
review board 2016 —
Extensive experience in patient safety and drug safety, been working for Inspektionen för Vård och
Omsorg, patientsakerhetsläkare, dug safety physician

Been working as Chief medical officer, medical responsible physician and medical lead

Deltar i följande:
Måndag 22/8 09:30-11:00 - SOTA1 Stockholm. When not to operate.
Måndag 22/8 09:50-10:10 - Anestesiologiska aspekter med data från SPOR

Eva Jangland är legitimerad sjuksköterska med specialistsjuk­sköterskeexamen inom kirurgisk vård. Hon är docent i omvårdnad och arbetar som universitetslektor i specialistsjuksköterskeprogrammet vid Uppsala universitet och har en förenad anställning vid verksamhetsområde kirurgi på Akademiska sjukhuset. Ett specifikt fokusområde i dag är kompetens och professionsutveckling för sjuksköterskor på alla nivåer och utveckling och tillämpning av det teoretiska ramverket Fundamentals of Care. Hon är forskargruppsledare för en forskargrupp inom omvårdnad som har fokus på personcentrerad grundläggande omvårdnad, ledarskap, kompetens och professionsutveckling hos sjuksköterskan. 

Deltar i följande:
Onsdag 24/8 08:30-09:30 - Vårdvetenskap Identifiera och möta omvårdnadsbehov - Rätt använd kompetens med efterföljande paneldiskussion
Onsdag 24/8 15:32-15:44 - What factors impact on professional development among specialist nurses in surgical care? A national focus group interview study
Onsdag 24/8 15:44-15:56 - What are the important factors for successful professional development for specialist nurses in surgical care? - a quantitative cross-sectional study
Tisdag 23/8 13:29-13:41 - Patients experience poor oral health and lack of oral care in surgical wards

Jag är universitetssjuksköterska inom intensivvård på Södersjukhuset, forskare, docent och lektor på Karolinska Institutet. Under många år jag har arbetat med införande av bedömningsskalor av vitalparametrar både lokalt, regionalt och nationellt. Deltog i arbetsgruppen som tog fram den svenska versionen av NEWS2 som lanserades nationellt i samarbete med Patientförsäkringen Löf 2018. Under föreläsningen kommer jag att prata om hur vi kan övervaka patienter på vårdavdelningar idag och i framtiden, och hur NEWS2 kan användas för att bedöma patientens behov av vårdnivå.

Deltar i följande:
Måndag 22/8 15:15-16:15 - Vårdvetenskap Identifiera och möta omvårdnadsbehov - övervakning och vårdnivå

Biträdande oppositionsråd för S i Region Stockholm med ansvar för personalfrågor och regional utveckling. I grunden spårvagnsmekaniker, men tröttnade och skaffade en kandidat i ekonomisk historia och en kandidat i sociologi. Sen decemeber 2018 tjänstledig f som hyresförhandlare för att vara regionråd.

Bor på Kungsholmen i Stockholm med fru (som jobbar inom akutsjukvården) och ett barn.

Deltar i följande:
Tisdag 23/8 10:15-11:45 - KIRUB Framtidens kirurger - Paneldebatt om den kirurgiska utbildningen

Akutläkare

Deltar i följande:
Torsdag 25/8 10:15-11:45 - Akutläkare - kirurgins räddning?

Dr. Kudsi is the Department Chair of Surgery, Director of Robotic Minimal Invasive Surgery Clinical & Research Fellowship at Steward Good Samaritan Medical Center.

 

He serves as the Co-chair of the Robotic Committee at the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), Associate Professor of Surgery at Tufts University School of Medicine.

 

Dr. Kudsi did his fellowships in MIS at Harvard and was the recipient of  IRCAD traveling award scholarship to France. He pursued a business degree with a focus on entrepreneurship and he is the founder of Robotic Surgery Collaboration (RSC) a vicarious learning platform dedicated to robotic surgery with over 13000 members. 

His research focus is on abdominal wall reconstruction, robotic surgery, vicarious learning, and optical scanning with over 60 original peer reviewed articles. He is the editor of four text books with over 100 national & international presentations and has taught over a 1000 surgeons. Dr. Kudsi has performed over 3400 robotic surgeries and has successfully assisted in setting up robotic programs in US, South America, Europe, and Asia.

Deltar i följande:
Onsdag 24/8 11:00-11:45 - Br J Surg föreläsning: Robotic General Surgery: The journey of 3400 Cases
Torsdag 25/8 14:30-15:15 - Intuitive Workshop M5. Introducing da Vinci in general surgical practice

Pernilla Lagergren är legitimerad sjuksköterska och professor i kirurgisk vårdvetenskap vid Karolinska Institutet i Stockholm och vid Imperial College London, Storbritannien. Hon disputerade i ämnet kirurgi på en avhandling om livskvalitet efter matstrupscancer 2006 och leder sedan dess en multidisciplinär forskningsgrupp vid Karolinska Institutet. Vid Imperial College London är hon bland annat ordförande för Healthcare Professional Academic Group (HPAG). Hennes huvudsakliga forskningsområde är ”survivorship” efter behandling för cancer i övre mag-tarmkanalen, med fokus på hälsorelaterad livskvalitet och andra patientrapporterade utfall hos patienter som opereras för matstrupscancer.

Deltar i följande:
Onsdag 24/8 13:15-14:45 - Vårdvetenskap Patientrapporterade utfallsmått i forskning och Psykologiska konsekvenser vid stor kirurgi
Onsdag 24/8 15:15-16:15 - Vårdvetenskap Fria föredrag
Onsdag 24/8 15:56-16:08 - Transanal irrigation minskar LARS-symtom och förbättrar livskvaliteten – resultat från en randomiserad kontrollerad studie
Måndag 22/8 16:30-16:30 - A randomized controlled clinical trial of transanal irrigation versus conservative treatment in patients with Low Anterior Resection Syndrome after rectal cancer surgery
Onsdag 24/8 13:15-14:00 - Patientrapporterade utfallsmått i forskning

Deltar i följande:
Torsdag 25/8 12:30-13:00 - Ethicon lunchsymposium; Positiv effekt med nya rutiner inom bröstkirurgi

Deltar i följande:
Torsdag 25/8 13:00-14:30 - SKF plenarsession. NPO - var står vi?

Thomas Lindén är chef för Avdelningen för Kunskapsstyrning för Hälso- och Sjukvården och ingår i ledningsgruppen på Socialstyrelsen. Thomas är regeringens chefläkare (Government CMO), är ordförande för Nationella Screeningrådet samt i Beredningsgrupp 1 i processen för nivåstrukturering av den nationella högspecialiserade vården.

Till professionen är Thomas läkare, specialist i neurologi och psykiatri och forskare, docent vid Göteborgs Universitet och gästprofessor i Melbourne, Australien och har främst studerat problem med minne, tänkande och känsloliv. Thomas har lång erfarenhet från chefs- och ledaruppdrag i sjukvården och kommer närmast från uppdraget som regionchefläkare i Halland med ansvar för kvalitet och patientsäkerhet och var där delaktig i uppbyggnaden av regionernas nationella kunskapsstyrning.

Deltar i följande:
Tisdag 23/8 10:15-11:45 - KIRUB Framtidens kirurger - Paneldebatt om den kirurgiska utbildningen

Deltar i följande:
Torsdag 25/8 10:15-11:45 - KIRUB Akuta bukväggsbråck - De svåra fallen, handläggning och åtgärder

Deltar i följande:
Torsdag 25/8 10:15-11:45 - Plastik ACTA Kirurgisk behandling av lymfödem
Torsdag 25/8 13:00-14:30 - SFFB/Plastik Direktrekonstruktion vid mastektomi med efterföljande strålbehandling. Evidens som talar för och emot, eller finns där evidens för en medelväg?
Fredag 26/8 08:54-09:00 - Learning Curve of Novel Robot-Assisted Microsurgery Techniques
Fredag 26/8 09:02-09:08 - Changes in Quality of Life (QoL) and Extremity Index in Patients with Lymphedema Treated with Microsurgical Lymphaticovenous Anastomosis (LVA)
Torsdag 25/8 15:35-15:40 - Prospective evaluation of complications and associated risk factors in breast cancer surgery

Professor Jaume Masia is Professor and Director of the Department of Plastic Surgery at Sant Pau Hospital - Universitat Autonoma de Barcelona, Barcelona, Spain.

 

 

After finishing his plastic surgery training and PhD in Barcelona, he complemented his training with fellowships in Canniesburn Hospital (Glasgow) and in Queen Victoria Hospital (East Grinstead), UK.

 

In 2001 he became plastic surgery consultant at Sant Pau University Hospital. Two years later he became the Chief of Microsurgery Unit and since 2007 is Chief of Plastic Surgery Department and Professor in Plastic Surgery at Universitat Autonoma de Barcelona.

 

Professor Masia was President of the Spanish Society of Plastic Surgery (SECPRE) in 2011-13 and President of Plastic Surgery Foundation for Education in 2014-15. Since 2010 he has been the Co-Director of the International Master’s Degree on Reconstructive Microsurgery and also Co-Director of the European Masters in Oncology, Reconstructive and Aesthetic Breast Surgery at Universitat Autonoma de Barcelona. Currently he is the President of the Educational Committee of the European Federation of Microsurgery Societies. He has been invited as lecturer and visiting Professor in more than one hundred international meetings in plastic surgery, author of several papers and books.

 

He has devoted a large part of the last 15 years to the improvement in lymphoedema treatment. He has explored early treatment and combination of different treatment methods as well as contributed to the education of plastic surgeons in lymphoedema and microsurgery through books, online-education, teaching and by organizing international meetings on the subject.

Deltar i följande:
Torsdag 25/8 10:15-11:45 - Plastik ACTA Kirurgisk behandling av lymfödem

Marie Morell

Åby, Norrköping, 53 år

Studerat sociologi, statsvetenskap, företagsekonomi mm vid Linköpings universitet

 

Oppositionsråd (M), Region Östergötland (1999-)

Gruppledare M-gruppen, Region Östergötland (2002-)

Ledamot regionfullmäktige Region Östergötland (1991-)

2:e vice ordförande, regionstyrelsen Region Östergötland (2014-)

Fd ordförande landstingsstyrelsen Landstinget i Östergötland (2006-2014)

Ordförande SKR:s Sjukvårdsdelegation (2019-) (ledamot sedan 2007)

Ordförande Kommunalförbundet Avancerad strålbehandling, Skandionkliniken (2019-)

Styrelseledamot Inera AB (2010-)

Ledamot Regeringens samverkansgruppför Hälsa och Life Science (2019-)

Ledamot Samverkansnämnden för Sydöstra sjukvårdsregionen (1999-)

Ledamot av styrgruppen för East Sweden MedTech (2020-

Deltar i följande:
Tisdag 23/8 10:15-11:45 - KIRUB Framtidens kirurger - Paneldebatt om den kirurgiska utbildningen

Deltar i följande:
Tisdag 23/8 12:30-13:00 - Medtronic lunchsymposium; Early experiences using Hugo RAS system.

Dr. Nannestad Jorgensen is the previous Chairman and current Vice-Chairman for the Danish Hernia Database and was president for the Joint Meeting of the Eur. & Am. Hernia Societies 13.-16 October 2021 in Copenhagen.

He has reviewed more than 20 international scientific journals and has been three times official opponent at foreign academic phd defense actions. International guidelines for inguinal hernia treatment and endoscopic surgery for abdominal wall hernia and several invited lecturer and chairman at international congresses and symposia.

He has completed supervision of 10 phd´s and mentored for 2 doctorial theses. Currently supervising 4 ph students. With 297 full papers; 17 book chapters and 38 correspondences/letters/editorials, he is passionated about and has a scientific focus area in Abdominal wall hernias, colorectal/pancreatic, wound healing, surgical tissue repair, postoperative complications, cancer and acute pancreatitis.

Deltar i följande:
Torsdag 25/8 14:30-15:15 - Intuitive Workshop M5. Introducing da Vinci in general surgical practice

Mikael Öman

är överläkare och docent i kirurgi vid Kirurgcentrum på Norrlands universitetssjukhus i Umeå. Forskningsintresset rymmer såväl cancer i bukspottkörtel och lever, som trauma, trafikforskning och gruppdynamik vid teamarbete. Varje år leder Mikael en mängd nationella kurser i trauma och kirurgisk teknik. Författare till ”Akutkirurgisk operationsmanual” med fokus på tvingande, temporära, transportsäkrande och terapeutiska öppna akuta ingrepp inom allmänkirurgi, kärlkirurgi, ortopedi, urologi, neurokirurgi och obstetrik. Mikael är reservofficer sedan 70-talet och har innehaft framträdande positioner på många nivåer inom Försvarsmakten, både i Sverige och vid utlandsmissioner.

Deltar i följande:
Tisdag 23/8 10:15-11:45 - KIRUB Framtidens kirurger - Paneldebatt om den kirurgiska utbildningen

MD, PhD, Consultant Surgeon at Mora hospital, Sweden.

My special field of interest is upper GI surgery including advanced laparoscopic hernia surgery. I was trained at Uppsala University Hospital where I also wrote my thesis about inflammatory reactions in peritonitis and malignant obstructive jaundice. Started with laparoscopic hernia surgery in the early 90´s. I have continued to develop the techniques and have been organizing courses and workshops, both in Sweden and abroad. I am a bord member of the Swedish Hernia Register since 2004 and chairman for GallRiks (Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography) since 2019. Before that I was the treasurer and the chairman of the Swedish Association for Innovative Surgical Technology (SIKT) for ten years. I am also a member of the SLAO medical advice board for Mountains Ski Accidents in Sweden, which gives clinical courses every winter Furthermore, I supervise doctoral students, my ongoing research revolves around hernia surgery, gallbladder- and obesity surgery, mostly based on data from our national registers. Finally, I am responsible for laparoscopic and simulator procedures at our clinic and have also responsibility as a study director for our residents in surgery.. In the spear time I like to be out in the nature, riding horses, going for cross country skiing or a downhill adventure.

Deltar i följande:
Torsdag 25/8 08:30-09:30 - SIKT Morgon-TV - urval av årets filmbidrag
Torsdag 25/8 10:15-11:45 - KIRUB Akuta bukväggsbråck - De svåra fallen, handläggning och åtgärder
Torsdag 25/8 10:31-10:39 - Increased glucose variability after gastric bypass and sleeve gastrectomy leads to a high proportion of patients with glucose concentrations in the hypoglycemic range
Torsdag 25/8 10:51-10:55 - Preoperativa alkoholproblem är en stark prediktor för postoperativa alkoholrelaterade hälsoproblem efter Roux-en-Y gastric bypass
Fredag 26/8 13:20-13:28 - Kirurgens och sjukhusets operationsvolym påverkar utfallet vid akut och elektiv kolecystektomi
Måndag 22/8 09:33-09:43 - Association Between Interrecti Distance and Abdominal Function Impairment in Women with Diastasis Recti Abdominis.
Måndag 22/8 09:53-10:03 - The impact of hospital level on the management of acute cholecystitis: A population-based study.

Deltar i följande:
Torsdag 25/8 10:15-11:45 - SFFB Targeted Axillary Dissection
Tisdag 23/8 13:05-13:17 - Patientrapporterade armbesvär och hälsorelaterad livskvalitet ett år efter sentinel node biopsi med eller utan axillutrymning från den randomiserade SENOMAC studien
Torsdag 25/8 15:45-15:53 - Bröstförstoring med fillers kan ge allvarliga komplikationer -en systematisk översiktsanalys och fallstudie
Fredag 26/8 08:38-08:44 - Reconstructive Options and Outcomes in Phyllodes Tumours and Sarcomas of the Breast. Results From a Population-Based Cohort
Torsdag 25/8 09:10-09:18 - AXSANA: an international prospective cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemot
Torsdag 25/8 09:18-09:30 - Long-term outcomes of immediate implant-based breast reconstruction with and without radiotherapy in a large population-based cohort of breast cancer patients
Torsdag 25/8 15:45-15:50 - Clinical Practice in the Management of Phyllodes Tumours and Sarcomas of the Breast: An International Study
Torsdag 25/8 09:02-09:10 - Long-term outcomes of immediate implant-based breast reconstruction in older adults - a large population-based cohort of breast cancer patients

Deltar i följande:
Tisdag 23/8 13:00-13:25 - Genius comes from serious games

Deltar i följande:
Tisdag 23/8 13:25-13:50 - How can the youngest get involved in the EAES (European Association of Endoscopic Surgery)?

Professor of Surgery

Head of Esophageal functional lab

Deltar i följande:
Torsdag 25/8 12:15-12:30 - Hiatal hernia repair: New trends in reflux

Jenny Sjödahl, Leg fysioterapeut, uroterapeut, med. Dr.

Fysioterapeutexamen 2004

Disputation 2010: muskelfunktion vid bäckensmärta

Uroterapeut sedan 2020

Tjänstgör sedan 2011 på neurogastromottagning och bäckenfunktionsenheten, Mag-Tarmmedicinska kliniken vid Universitetssjukhuset i Linköping

Deltar i följande:
Tisdag 23/8 11:15-11:45 - Kolorektal Mini-SOTA 1: Anorektala funktionsstörningar.

Gästföreläsare SFFB kirurgveckan 2022

 

Prof. dr. Dr. Marjolein Smidt has been working as a surgeon at Maastricht UMC+ since 2008 and is specialized in breast cancer surgery. In 1997 she obtained her medical exam cum laude at the University of Maastricht. After her training, Prof. Dr. Marjolein Smidt further specialized in laparoscopic surgery at the St. Franciscus Gasthuis in Rotterdam. In 2006 she obtained her PhD with her thesis entitled 'The sentinel lymph node in breast cancer patients: an evaluation of new developments in clinical practice'.

 

Prof. dr. Dr. Smidt is conducting research into axillary gland metastases in collaboration with the Radiology department. In recent years, survival for breast cancer patients has become so good that more attention is being paid to the side effects of the treatment, for example lymphedema as a result of the armpit surgery. If this is possible, no more surgery is required. She is also involved in international cooperation in the field of breast surgery.

 

During the last decades, breast cancer survival increased impressively as a consequence of extensive adjuvant treatment. Consequently attention shifted from only survival to a combined endpoint including both survival and Qol. This attention shift resulted in the question: “How can we limit overtreatment?”. All research prof. dr. Smidt performs suits this qualification.

 

Concerning axillary treatment, the ultimate treatment goal is equally safe though with less lifelong morbidity. Therefore she is interested in noninvasive nodal staging study with (PET)MRI, which has the potential to offer the same knowledge as the operative axillary staging without operation. In case of omission of any axillary operation, chances for complications like shoulder stiffness and lymphedema, all significantly impacting quality of life, will drop to almost zero.

 

Her goals are also supported by the BOOG 2013-08, RISAS- and MINIMAX-study. All these studies are focused on de-escalation of axillary treatment.

· The BOOG 2013-08 RCT investigates the added value of the sentinel lymph node biopsy (SLNB) in clinical node negative breast cancer patients treated with breast conserving therapy. The study just finished the randomizing phase with inclusion of 1730 patients, which might be seen as an impressive achievement.

 

· The RISAS-study investigated the value of the RISAS-procedure as staging procedure in clinically node positive patients neoadjuvant setting. The RISAS-procedure proved to be the most accurate procedure compared to the marked node and sentinel lymph node biopsy. Thereby it has the highest chance of identification of complete response (when adjuvant regional treatment can be omitted, thereby preventing morbidity and its impact on Qol). At the same time, accurate identification of remaining disease can instigate adjuvant systemic therapy, thereby increasing overall survival. In the Netherlands the RISAS-procedure is the preferred staging procedure now.

Prof. dr. Smidt collaborates with international principal investigators of comparable studies aiming to empower outcome and catalyze implementation.

 

She is further developing a breast cancer related prevention program. Lifestyle, like alcohol intake and BMI, has proven to highly impact breast cancer incidence as well as recurrence. By providing this knowledge to patients, they have the information to take something in their rollercoaster breast cancer era in their own hands. These patients are supported by dieticians, physiotherapists or lifestyle coaches, depending on the provided breast cancer treatment.

Deltar i följande:
Torsdag 25/8 10:15-11:45 - SFFB Targeted Axillary Dissection

Deltar i följande:
Tisdag 23/8 08:30-09:30 - KIRUB Tarmsvikt - Prevention och behandling

Deltar i följande:
Torsdag 25/8 10:15-11:45 - Akutläkare - kirurgins räddning?

Deltar i följande:
Måndag 22/8 15:15-16:15 - KIRUB ERCP . Inte en oskyldig undersökning

Amir Szold, MD, is a pioneer laparoscopic surgeon, trained in surgery in Hadassah Medical Center in Jerusalem and Mount Sinai Medical Center New York. In the late 90’s he was the founder and first president of the Israeli Society of Endoscopic Surgery, and was a Board Member, and the Technology Committee Chairman, European Association of Endoscopic Surgeons, a member in the Technology Committee of SAGES, and Board Member, Israeli Society of Surgeons. He currently serves in the Steering Committee of iSMIT and an Editor of MITAT. Dr. Szold has publishes over 100 papers in peer reviewed journals, presented hundreds of presentations in International congresses, and performed many international live-surgery workshops.

Dr. Szold is heavily involved in medical innovation. He is the Founder, advisor and board member in multiple medical device startup companies in Israel and Europe, covering fields of 3D vision, robotics, soft tissue replacements, surgical glues, laser technology, smart materials and laparoscopic devices.  He is a member of the lucrative 8400 Healthcare Network, the Founder and Medical Director of Assia Medical Group in Tel Aviv, and the co-founder and current advisor of the Physicians for Human Rights volunteer clinic for illegal immigrants and refugees, Tel Aviv, Israel.

Deltar i följande:
Måndag 22/8 13:00-13:25 - Robots and flexible tech
Måndag 22/8 14:00-14:20 - From surgeon to entreprenör: is it possible?

Thomas Troëng kirurgen, kärlkirurgen och klinikchefen från Karlskrona en nestor inom gebitet kvalitetsregister. Med Vascular Registry in Sothern Sweden (VRISS) debuterade han och nu är han sedan många år intimt förknippad med SWEDVASC som han odlade fram ur VRISS. Men Thomas Troeng har sitt finger med i mycket av den svenska framgången inom gebitet kvalitetsregister. Hans avhandling bar undertiteln ”learning from experience” ett viktigt skäl till att registrera och räkna. Rätt utfört blir vi registrerade och räknas av vår omgivning.

Deltar i följande:
Torsdag 25/8 10:15-11:45 - SVESEK Kvalitetsregister, en svensk exportartikel.

Carolynne Jane Vaizey was educated at Cape Town University and then trained in General and Trauma Surgery up to consultant level in Johannesburg. She has worked in UK since 1992 and after taking UK surgical examinations she took up a research post at St Mark’s Hospital to obtain an MD through the University of London.

At the beginning of 1998 she became a Consultant Colorectal Surgeon at the Middlesex & University College Hospitals in Central London and Honorary Senior Lecturer at University College London. In 2003 she took up a new post as Consultant Surgeon at St Mark’s Hospital and Honorary Senior Lecturer at Imperial College.

Miss Vaizey has interests in the management of intestinal failure and surgical disasters, severe Crohn’s, fecal incontinence, anal surgery and functional bowel disease. She is the Lead Surgeon for Intestinal Failure at St Mark’s and Director of the Physiology unit. She is also the Divisional Clinical Director for the division of surgery, St Mark’s, anesthesia, and theatre for LNWUH NHS trust. She has written 18 book chapters on her specialty interests and has over 150 papers and editorials published or in press.

She is the Chair of the European Society of Coloproctology’s Guidelines Committee and a member of their Executive and Research committees. She Chairs the Committee for Commissioning Guidelines for Fecal Incontinence for NHS England and has been a core member of the Clinical Team advising NHS England on Intestinal Failure Services in England.

Deltar i följande:
Tisdag 23/8 13:00-14:30 - Kolorektal Mini-SOTA 2+3: Congenital and functional anorectal disorders
Tisdag 23/8 13:45-14:30 - Surgical treatment of anorectal functional disorders

Antonios Valachis är docent i Onkologi sedan 2018 och överläkare på Onkologiska Kliniken USÖ. Hans kliniska arbete och forskning handlar om bröstcancer och melanom.

Han har pågående projekt under följande forskningsämnen:

• Farmakoepidemiologiska studier kring interaktioner mellan icke-cancerläkemedel och cancerläkemedel vid bröstcancer samt långvariga biverkningar av onkologisk behandling mot bröstcancer


• Prognos och molekylär kartläggning av ovanliga subtyper av bröstcancer (metaplastisk bröstcancer)


• Användning av artificiell intelligens för att förbättra livskvalitet hos patienter med bröst- och prostatacancer (Europeiskt projekt finansierat av EU Horizon 2020)


• Prediktiva markörer vid immunterapi vid metastaserat malignt melanom


• Optimering av neoadjuvant behandling vid bröstcancer


• Aspekter kring immunterapi i klinisk praxis


• Prediktiva markörer för exceptionell respons på målstyrd onkologisk behandling mot bröstcancer

Deltar i följande:
Fredag 26/8 12:00-13:30 - SFFB Det andra bröstet
Torsdag 25/8 08:54-09:02 - Breast cancer in older women - long-term prognosis by age and subtype

Deltar i följande:
Tisdag 23/8 15:15-16:15 - KIRUB Neurotrauma - Akut och vidarevård

Education:

 

2016 Special competence in wound care, The Finnish Medical Association

2015 Adjunct professor, vascular surgery, University of Helsinki

2012 Doctor of Medical Science (D.Med.Sci.) University of Helsinki

2004 Specialist in Vascular Surgery, University of Helsinki

2003 General Medical Council approval of general practice in GB

2001 Approval of Completion of General Surgical Service

1998 Licensed physician (EU laws)

1996 Medical Doctor (MD), University of Helsinki

 

 

Professional appointments:

 

Apr 19- Chief physician, vascular surgery Helsinki University Hospital

04 -19 Consultant, vascular surgery, Helsinki university Hospital

May 22- Senior medical officer in charge of preparedness, Meilahti Hospital

12-19 Director, surgical services, HYKSin Oy

08 - cont Vascular surgeon, Mehiläinen, Private Hospital

08 Honorary lecturer, Queen Elisabeth Hospital, Bridgetown, Barbados (2 months)

01-04 Surgical senior registrar, Helsinki University Central Hospital, Vascular sur-gery

03 Clinical Honorary Fellow, Manchester Royal Infirmary, NHS, GB (4 mnths)

00-01 Surgical trainee Helsinki University Central Hospital

98-99 Surgical trainee - Helsinki City Hospital

98-04 General practitioner and minor surgery, private practice 4-6h / week. DIACOR

97-98 GP, Punavuori health care centre

95-97 Trainee, ENT clinic, Helsinki University Central Hospital

94-95 Military doctor, Porkkala military hospital, Upinniemi

 

Military rank

 

Medical captain, (airborne rangers 1989, officer of the year)

 

 

 

Positions of trust

 

21- President, Finnish Society of Surgery (FSS)

19-21 Vice president, FSS

13-19 Treasurer, FSS

09 -11 Secretary General, FSS

07-09 2nd Secretary FSS

17- Director, European Society for Vascular Surgery (ESVS) Board of directors

16- Treasurer, ESVS executive committee

21-22 Associate editor, Scandinavian Journal of Surgery, cardiovascular section

14-22 Scientific advisory board, Finnish National guidelines, Current Care of stroke, Updates

10-14 Board member, Finnish trauma association

11-13 General Secretary, Local organising committee International surgical week Helsinki, 2013

10-11 Scientific advisory board, Finnish National guidelines, Current Care of stroke

05 LOC member, ESVS annual meeting Helsinki,

03-06 Finnish national representative, Scand Ass Vasc Surg, Educational Committee

04 Secretary, Finnish Society for Vascular Surgery

01-04 Vice chairman, Finnish Society for Vascular Surgery

01-04 Finnish national representative, European Association for Vascular Surgeons in Training

01-04 Board member, Diadoc (organisation for private practitioners in Diacor)

 

Opponent tasks for doctoral degree

 

2021 Henna Jaurila MD, Tissue repair and metabolic dysfunction, University of Oulu

2021 Fredrik Sartipy MD, Cardiovascular risk assessments in peripheral arterial disease-results of a the-year follow-up of Swedish population-based cohort. Karolinska Institutet, Stockholm, Sweden

2021 Iisa Lindström, MD, Sarcopenia as a predictor of survival in vascular patients. Tampere University

 

 

Thesis

 

Carotid surgery – A posse ad esse non valet consequentia

University of Helsinki.2011

Opponent: Prof AR Naylor

Deltar i följande:
Fredag 26/8 10:15-10:33 - Onkovaskulär kirurgi i Helsingfors

Deltar i följande:
Torsdag 25/8 10:15-11:45 - SFFB Targeted Axillary Dissection
Torsdag 25/8 15:15-15:20 - A prospective comparison of skin staining after sentinel lymph node biopsy in patients with breast cancer, using blue dye (PB) and superparamagnetic iron oxide nanoparticles (SPIO) tracers.
Torsdag 25/8 15:20-15:25 - Using an ultra-low dose of superparamagnetic iron oxide for sentinel lymph node detection in breast cancer patients - the MAGSNOW feasibility study
Torsdag 25/8 15:25-15:30 - SentiNeo: a magnetic method for sentinel lymph node biopsy and targeted axillary dissection (TAD) after neoadjuvant chemotherapy. A feasibility study report.
Torsdag 25/8 15:30-15:35 - The impact of a surgical care bundle on surgical site infections in breast cancer patients
Fredag 26/8 08:30-08:40 - Angiosarcoma in the breast: a population-based cohort from Sweden
Fredag 26/8 08:50-09:00 - PREDICT: Förändrade strålbehandlingsrekommendationer för kvinnor med DCIS baserat på biosignaturen DCISionRT; en interimsanalys av en amerikansk prospektiv registerstudie
Fredag 26/8 09:00-09:10 - Proteogenomic analysis identifies differential evolutionary pathways of local recurrences in breast cancer

Jonathan Zager is the Chief Academic Officer and a surgical oncologist and Senior Member in the Departments of Cutaneous Oncology and Sarcoma at Moffitt Cancer Center. Dr. Zager is the Director of Regional Therapies at Moffitt’s Donald A. Adam Comprehensive Melanoma Research Center. Dr. Zager is a Professor of Surgery at the University of South Florida, Morsani School of Medicine. Dr. Zager’s research and clinical interests include the regional therapy treatment of cutaneous melanoma and non-melanoma skin cancers, soft tissue sarcomas. Dr. Zager is internationally known for the management and study of locoregionally recurrent melanoma, non-melanoma skin cancer and soft tissue sarcoma. In particular conducting clinical trials for these clinical scenarios using regional therapies such as, intralesional injections using oncolytic viruses and isolated limb infusions for in transit or recurrent extremity melanoma and unresectable extremity sarcomas as well as performing percutaneous hepatic perfusions for unresectable melanoma to the liver. Dr. Zager graduated magna cum laude from Sackler School of Medicine’s New York State/American Program. He served a junior residency at North Shore University Hospital-New York University School of Medicine and was a research fellow at Memorial-Sloan Kettering Cancer Center before completing residency in surgery at Montefiore Medical Center-Albert Einstein College of Medicine, Where he was chief resident his last year. Dr. Zager completed fellowship training in surgical oncology at the University of Texas-M.D. Anderson Cancer Center. Dr. Zager has received numerous awards, including Best Doctors in America, America’s Top Oncologists, Top Doctors in Tampa Bay, Castle Connolly Top Doctors, Patients Choice Physician Awards and Clinical Educator and Mentor of the Year four times at Moffitt Cancer Center. He is a member of numerous editorial and advisory boards and professional organizations, including the Sentinel Node Oncology Foundation executive committee as well as the on the executive council of the Society of Surgical Oncology. Dr. Zager is the Director of Student Research in the Department of Cutaneous Oncology including the 8 week Summer Student Research Internship and the Program Director of the Surgical Oncology Research Fellowship Program.  Dr. Zager serves as Moffitt Cancer Center's Designated Institutional Official for their ACGME accreditation.

Deltar i följande:
Fredag 26/8 10:15-11:45 - SFFB Neoadjuvant treatment in melanoma + fria föredrag melanom